Mesalamine (Mesalazine)
Home / API - Commercial / Mesalamine (Mesalazine)
CAS No.
89-57-6
Therapeutic Category
- Anti-inflammatory
Innovator Brand
PENTASA , SALOFALK , ASACOL , OCTASA , CLAVERSAL , MEZAVANT , MESAVANCOL , LIXACOL ,
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis. Prescribing information for mesalazine in the uk also indicates the medication for the maintenance of remission of crohn’s ileo-colitis
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.